Abstract
The efficacies of meropenem (MPM) and cloxacillin (CLC) against two Staphylococcus aureus strains were established in vitro. A pharmacodynamic model equation, based on the concept that the killing rate depends on concentration and time, was fitted to the numbers of CFU. The parameters of the equation are maximum killing rate, time point of maximum killing, and 50% effective concentration (EC50). The EC50s for the two strains were 0.047 and 0.040 mg/liter, respectively, for MPM and 0.105 and 0.121 mg/liter, respectively, for CLC. Calculated values of the parameters were used to predict the numbers of CFU at exponentially decreasing concentrations in vitro as well as in an experimental infection model. The prediction for in vitro conditions gave a satisfactory fit (R2, between 0.862 and 0.894). In vivo the numbers were predicted with the assumption that killing rate in vivo is proportional to that in vitro (R2, between 0.731 and 0.973). The proportionality factor ranged between 0.23 and 0.42; this variation was due mainly to covariation with growth rates in control animals, without other significant differences between antibiotics or strains.
Full Text
The Full Text of this article is available as a PDF (216.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Mattie H., Sekh B. A., van Ogtrop M. L., van Strijen E. Comparison of the antibacterial effects of cefepime and ceftazidime against Escherichia coli in vitro and in vivo. Antimicrob Agents Chemother. 1992 Nov;36(11):2439–2443. doi: 10.1128/aac.36.11.2439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mattie H., van Dokkum A. M., Brus-Weijer L., Krul A. M., van Strijen E. Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics. J Infect Dis. 1990 Sep;162(3):717–722. doi: 10.1093/infdis/162.3.717. [DOI] [PubMed] [Google Scholar]
- Moffie B. G., Hoogeterp J. J., Lim T., Douwes-Idema A. E., Mattie H. Effectiveness of netilmicin and tobramycin against Pseudomonas aeruginosa in vitro and in an experimental tissue infection in mice. J Antimicrob Chemother. 1993 Mar;31(3):403–411. doi: 10.1093/jac/31.3.403. [DOI] [PubMed] [Google Scholar]
- Peetermans W. E., Hoogeterp J. J., Hazekamp-van Dokkum A. M., van den Broek P., Mattie H. Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection. Antimicrob Agents Chemother. 1990 Oct;34(10):1869–1874. doi: 10.1128/aac.34.10.1869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tuomanen E., Cozens R., Tosch W., Zak O., Tomasz A. The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol. 1986 May;132(5):1297–1304. doi: 10.1099/00221287-132-5-1297. [DOI] [PubMed] [Google Scholar]
- Vogelman B., Gudmundsson S., Leggett J., Turnidge J., Ebert S., Craig W. A. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis. 1988 Oct;158(4):831–847. doi: 10.1093/infdis/158.4.831. [DOI] [PubMed] [Google Scholar]